{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:24:50Z","timestamp":1783103090955,"version":"3.54.6"},"reference-count":57,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cystic fibrosis (CF) is a multisystemic genetic disorder caused by dysfunctional CF transmembrane conductance regulator (CFTR) protein, leading to impaired chloride and bicarbonate transport. Advances in care have increased patient lifetime, revealing chronic complications such as CF-related bone disease (CFBD), characterized by low bone mineral density and increased fracture risk. CFBD results from a complex interplay of factors including chronic inflammation, nutritional deficiencies, hormonal imbalances, and impaired glucose metabolism. Pro-inflammatory cytokines (e.g., TNF-\u03b1, IL-1\u03b2, IL-6, and IL-8) promote osteoclastogenesis, disrupting bone remodeling via the RANK\/RANKL\/OPG pathway. In vivo murine and in vitro studies have elucidated the pathogenic mechanisms underlying CFBD, highlighting CFTR\u2019s role in bone cell function. Diagnosis is based on clinical evaluation, bone densitometry, and laboratory assessments of bone metabolism markers. In this narrative review we highlight the recent scientific evidence on the etiopathogenesis and the current strategies for management of CFBD.<\/jats:p>","DOI":"10.3390\/jcm14165657","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T09:59:13Z","timestamp":1754906353000},"page":"5657","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bone Disease in Cystic Fibrosis: Insights into Etiopathogenesis and Advances in Treatment Management"],"prefix":"10.3390","volume":"14","author":[{"given":"Paola","family":"Giordano","sequence":"first","affiliation":[{"name":"Pediatric Unit \u201cB. Trambusti\u201d, Cystic Fibrosis Regional Reference Center, Department of Interdisciplinary Medicine, University of Bari \u201cAldo Moro\u201d, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Linguiti","sequence":"additional","affiliation":[{"name":"Pediatric Unit \u201cB. Trambusti\u201d, Cystic Fibrosis Regional Reference Center, Department of Interdisciplinary Medicine, University of Bari \u201cAldo Moro\u201d, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Leonetti","sequence":"additional","affiliation":[{"name":"Pediatric Unit \u201cB. Trambusti\u201d, Cystic Fibrosis Regional Reference Center, Department of Interdisciplinary Medicine, University of Bari \u201cAldo Moro\u201d, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria Pia","family":"Casolino","sequence":"additional","affiliation":[{"name":"Pediatric Unit \u201cB. Trambusti\u201d, Cystic Fibrosis Regional Reference Center, Department of Interdisciplinary Medicine, University of Bari \u201cAldo Moro\u201d, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Granberg","sequence":"additional","affiliation":[{"name":"Pediatric Unit \u201cB. Trambusti\u201d, Cystic Fibrosis Regional Reference Center, Department of Interdisciplinary Medicine, University of Bari \u201cAldo Moro\u201d, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1899-8337","authenticated-orcid":false,"given":"Maria Felicia","family":"Faienza","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari \u201cAldo Moro\u201d, Piazza G. Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/rccm.201504-0656UP","article-title":"Update in Cystic Fibrosis 2014","volume":"192","author":"Ong","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13023-024-03506-1","article-title":"Diagnosing Cystic Fibrosis in Low- and Middle-Income Countries: Challenges and Strategies","volume":"19","author":"Fuhrer","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fonseca, \u00d3., Gomes, M.S., Amorim, M.A., and Gomes, A.C. (2023). Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation. Biomolecules, 13.","DOI":"10.3390\/biom13030425"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ncp.11332","article-title":"Evolving Nutrition Therapy in Cystic Fibrosis: Adapting to the CFTR Modulator Era","volume":"40","author":"Vavrina","year":"2025","journal-title":"Nutr. Clin. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"115929","DOI":"10.1016\/j.bone.2021.115929","article-title":"Evaluation of Bone Metabolism in Children with Cystic Fibrosis","volume":"147","year":"2021","journal-title":"Bone"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/jbmr\/zjae139","article-title":"Longitudinal Changes in BMD in Adults with Cystic Fibrosis","volume":"39","author":"Jad","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20420188251328210","DOI":"10.1177\/20420188251328210","article-title":"Cystic Fibrosis-Related Bone Disease: An Update on Screening, Diagnosis, and Treatment","volume":"16","author":"Cobb","year":"2025","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/thorax.55.9.798","article-title":"Osteoporosis and Osteopenia in Adults and Adolescents with Cystic Fibrosis: Prevalence and Associated Factors","volume":"55","author":"Conway","year":"2000","journal-title":"Thorax"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1164\/ajrccm.162.3.9910118","article-title":"Bone Density, Body Composition, and Inflammatory Status in Cystic Fibrosis","volume":"162","author":"Ionescu","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jcf.2019.08.017","article-title":"Cystic Fibrosis Bone Disease Treatment: Current Knowledge and Future Directions","volume":"18","author":"Putman","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13514","DOI":"10.3390\/cimb46120807","article-title":"The Anti-Inflammatory Roles of Vitamin D for Improving Human Health","volume":"46","author":"Fenercioglu","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in Bone Modeling and Remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"116540","DOI":"10.1016\/j.bone.2022.116540","article-title":"Cytokine-Mediated Immunomodulation of Osteoclastogenesis","volume":"164","author":"Zhou","year":"2022","journal-title":"Bone"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Shen, W.R., Qi, J., Nara, Y., Pramusita, A., Kinjo, R., and Mizoguchi, I. (2020). Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145169"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Houschyar, K.S., Tapking, C., Borrelli, M.R., Popp, D., Duscher, D., Maan, Z.N., Chelliah, M.P., Li, J., Harati, K., and Wallner, C. (2019). Wnt Pathway in Bone Repair and Regeneration\u2014What Do We Know So Far. Front. Cell Dev. Biol., 6.","DOI":"10.3389\/fcell.2018.00170"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21162","DOI":"10.1074\/jbc.M501900200","article-title":"Essential Role of \u03b2-Catenin in Postnatal Bone Acquisition","volume":"280","author":"Holmen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12519-018-0198-7","article-title":"An Update on the Role of RANKL\u2013RANK\/Osteoprotegerin and WNT-\u00df-Catenin Signaling Pathways in Pediatric Diseases","volume":"15","author":"Brunetti","year":"2019","journal-title":"World J. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Faienza, M.F., Ventura, A., Colucci, S., Cavallo, L., Grano, M., and Brunetti, G. (2016). Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies. Front. Endocrinol., 7.","DOI":"10.3389\/fendo.2016.00034"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bone.2015.07.021","article-title":"Mechanisms of Enhanced Osteoclastogenesis in Girls and Young Women with Turner\u2019s Syndrome","volume":"81","author":"Faienza","year":"2015","journal-title":"Bone"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ppul.24129","article-title":"Inflammation in Cystic Fibrosis: An Update","volume":"53","author":"Roesch","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2036.2004.02097.x","article-title":"Effect of Antitumour Necrosis Factor-\u03b1 Therapy on Bone Turnover in Patients with Active Crohn\u2019s Disease: A Prospective Study","volume":"20","author":"Ryan","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"758148","DOI":"10.1155\/2015\/758148","article-title":"Skeleton and Glucose Metabolism: A Bone-Pancreas Loop","volume":"2015","author":"Faienza","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4239\/wjd.v12.i7.997","article-title":"Mechanisms of Altered Bone Remodeling in Children with Type 1 Diabetes","volume":"12","author":"Brunetti","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.bone.2009.12.002","article-title":"The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Is Expressed in Maturation Stage Ameloblasts, Odontoblasts and Bone Cells","volume":"46","author":"Bronckers","year":"2010","journal-title":"Bone"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18009","DOI":"10.1074\/jbc.M115.646208","article-title":"Increased NF-\u03baB Activity and Decreased Wnt\/\u03b2-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in \u0394F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice","volume":"290","author":"Mansouri","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcf.2025.01.005","article-title":"CFTR Mutation Is Associated with Bone Differentiation Abnormalities in Cystic Fibrosis","volume":"24","author":"Dumortier","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bone.2004.05.021","article-title":"Severe Osteopenia in CFTR-Null Mice","volume":"35","author":"Dif","year":"2004","journal-title":"Bone"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.200705-659OC","article-title":"Persistent Osteopenia in Adult Cystic Fibrosis Transmembrane Conductance Regulator\u2013Deficient Mice","volume":"177","author":"Haston","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcf.2010.05.001","article-title":"Osteopenia in Cftr-deltaF508 Mice","volume":"9","author":"Paradis","year":"2010","journal-title":"J. Cyst. Fibros."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.ajpath.2012.01.039","article-title":"The F508del Mutation in Cystic Fibrosis Transmembrane Conductance Regulator Gene Impacts Bone Formation","volume":"180","author":"Gimenez","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1203\/PDR.0b013e3181961e80","article-title":"Murine Model for Cystic Fibrosis Bone Disease Demonstrates Osteopenia and Sex-Related Differences in Bone Formation","volume":"65","author":"Pashuck","year":"2009","journal-title":"Pediatr. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Stalvey, M.S., Clines, K.L., Havasi, V., McKibbin, C.R., Dunn, L.K., Chung, W.J., and Clines, G.A. (2013). Osteoblast CFTR Inactivation Reduces Differentiation and Osteoprotegerin Expression in a Mouse Model of Cystic Fibrosis-Related Bone Disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080098"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/hmg\/ddw009","article-title":"Genetic Deletion of Keratin 8 Corrects the Altered Bone Formation and Osteopenia in a Mouse Model of Cystic Fibrosis","volume":"25","author":"Hatton","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thx.2006.075887","article-title":"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Is Expressed in Human Bone","volume":"62","author":"Shead","year":"2007","journal-title":"Thorax"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Divangahi, M., Balghi, H., Danialou, G., Comtois, A.S., Demoule, A., Ernest, S., Haston, C., Robert, R., Hanrahan, J.W., and Radzioch, D. (2009). Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis Mice. PLoS Genet., 5.","DOI":"10.1371\/journal.pgen.1000586"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcf.2009.11.005","article-title":"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Regulates the Production of Osteoprotegerin (OPG) and Prostaglandin (PG) E2 in Human Bone","volume":"9","author":"Guillaume","year":"2010","journal-title":"J. Cyst. Fibros."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcf.2004.05.039","article-title":"Animal Models of Cystic Fibrosis","volume":"3","author":"Scholte","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1183\/09031936.04.00050204","article-title":"Reduced Bone Density in Cystic Fibrosis: \u0394F508 Mutation Is an Independent Risk Factor","volume":"25","author":"King","year":"2005","journal-title":"Eur. Respir. J."},{"key":"ref_39","first-page":"373","article-title":"Use of CTX-I and PINP as Bone Turnover Markers: National Bone Health Alliance Recommendations to Standardize Sample Handling and Patient Preparation to Reduce Pre-Analytical Variability","volume":"76","author":"Szulc","year":"2018","journal-title":"Ann. Biol. Clin."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jocd.2017.06.019","article-title":"Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-Energy X-Ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice","volume":"20","author":"Shevroja","year":"2017","journal-title":"J. Clin. Densitom."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bergagnini-Kolev, M.C., Hsu, S., Aitken, M.L., Goss, C.H., Hoofnagle, A.N., Zelnick, L.R., Lum, D., Best, C.M., Thummel, K.E., and Kestenbaum, B.R. (2023). Metabolism and Pharmacokinetics of Vitamin D in Patients with Cystic Fibrosis. J. Steroid Biochem. Mol. Biol., 232.","DOI":"10.1016\/j.jsbmb.2023.106332"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41043-024-00499-2","article-title":"Vitamin D Deficiency in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis","volume":"43","author":"Farahbakhsh","year":"2024","journal-title":"J. Health Popul. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS Guideline on Nutrition Care for Cystic Fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Bertoldo, F., Cianferotti, L., Di Monaco, M., Falchetti, A., Fassio, A., Gatti, D., Gennari, L., Giannini, S., Girasole, G., and Gonnelli, S. (2022). Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients, 14.","DOI":"10.3390\/nu14194148"},{"key":"ref_45","unstructured":"(2011). Dietary Reference Intakes for Calcium and Vitamin D, National Academies Press."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10534-021-00305-0","article-title":"An Update on Magnesium and Bone Health","volume":"34","author":"Rondanelli","year":"2021","journal-title":"BioMetals"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Serna, J., and Bergwitz, C. (2020). Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging. Nutrients, 12.","DOI":"10.3390\/nu12103001"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.2169\/internalmedicine.0905-18","article-title":"Diabetes Mellitus-Induced Bone Fragility","volume":"57","author":"Kanazawa","year":"2018","journal-title":"Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European Cystic Fibrosis Bone Mineralisation Guidelines","volume":"10","author":"Bianchi","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Faienza, M.F., Urbano, F., Chiarito, M., Lassandro, G., and Giordano, P. (2023). Musculoskeletal Health in Children and Adolescents. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1226524"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coemr.2019.04.006","article-title":"Exercise and the Growth Hormone\u2013Insulin-like Growth Factor Axis","volume":"9","author":"Birzniece","year":"2019","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"ref_52","first-page":"CD002010","article-title":"Bisphosphonates for Osteoporosis in People with Cystic Fibrosis","volume":"1","author":"Conwell","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_53","first-page":"100291","article-title":"Treatment of Cystic Fibrosis Related Bone Disease","volume":"27","author":"Ullal","year":"2022","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_54","unstructured":"Hildebrand, G.K., Patel, P., and Kasi, A. (2025). Denosumab. StatPearls, StatPearls Publishing."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11914-019-00502-4","article-title":"Stopping Denosumab","volume":"17","author":"Lamy","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab Treatment in Postmenopausal Women with Osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5657\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:27:38Z","timestamp":1760034458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":57,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165657"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165657","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,10]]}}}